Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes-Reference-Cited by-同舟云学术

Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes

Published:2021-09 Issue:9 Volume:5 Page:838-849
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Gupta Mrinali P.,Koenig Lisa R.,Doubrovina Ekaterina,Hasan Aisha,Dahi Parastoo B.,O’Reilly Richard J.,Koehne Guenther,Orlin Anton,Chan Robison V. Paul,D’Amico Donald J.,Park Susanna S.,Burkholder Bryn M.,Kiss Szilárd

Funder

Atara Biotherapeutics

Research to Prevent Blindness

Novartis

Allergan

Publisher

Elsevier BV

Subject

Ophthalmology

Reference12 articles.

1. Cytomegalovirus and the eye;Carmichael;Eye,2012

2. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy;Sugar;Am J Ophthalmol,2012

3. Cytomegalovirus retinitis in the post-cART era;Port;Curr Ophthalmol Rep,2018

4. Cytomegalovirus retinitis: a review;Port;J Ocul Pharmacol Ther,2017

5. Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature;Downes;J Ophthalmic Inflamm Infect,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment;Viruses;2024-09-07

3. Clinical features of cytomegalovirus retinitis, A retrospective analysis of 90 patients;2024-08-09

4. The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis;Ocular Immunology and Inflammation;2024-02-08

5. Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases;Pharmaceutics;2023-06-15